PRECEPTORSHIP PROGRAM: Acquired and Inherited Aplastic Anemia in pediatric and adult
ERN-EuroBloodNet is endorsing via EuroBloodNet Association one preceptorship held in ERN-EuroBloodNet highly specialized center for Aplastic Anemia (AA) to provide applicants with the fundamental tools for a correct diagnostic and treatment approach to Aplastic Anemia, adolescents, and adult patients.
This preceptorship aims to:
-
Train medical residents in haematology and young haematologists in patient care, including diagnostic tools, optimal use of available and new drugs, and in the field of Aplastic Anemia supportive care
-
Learn or improve medical resident in haematology and young haematologists knowledge in clinical research, including participation to registries and clinical trials
-
Stimulate cross-border collaborations between medical residents in haematology and young haematologists
Participants must be affiliated to European Member States Healthcare providers.
Preceptorship on AA and PNH, developed within the ERN-EuroBloodNet framework, is sponsored by EuroBloodNet Association throught a grant supported by Pfizer.
Discover further details for participation in the educational program document (submission procedure, selection procedure, deadlines...).
CALL FOR PRECEPTORSHIP OPENED:
-
Host Member: Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.
-
Coordinators: Prof. Régis Peffault de Latour
-
Dates: 28th of September to 2nd of October 2026
-
Deadline submission: 15st of June 2026 (23:59 CEST time)
-
Further details:
The ERN-EuroBloodNet Preceptorship is under accreditation with Continuous Medical Education points from the European Board of Accreditation in Hematology (EBAH).
